BlackRock Inc. - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 176 filers reported holding HERON THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,370,656
-13.9%
8,126,849
-3.0%
0.00%
Q2 2023$9,716,820
-31.6%
8,376,568
-10.9%
0.00%
Q1 2023$14,195,634
-41.2%
9,401,084
-2.6%
0.00%
-100.0%
Q4 2022$24,126,777
-38.2%
9,650,709
+4.2%
0.00%0.0%
Q3 2022$39,071,000
+59.2%
9,258,303
+5.3%
0.00%0.0%
Q2 2022$24,540,000
-47.4%
8,795,900
+7.8%
0.00%0.0%
Q1 2022$46,650,000
-33.5%
8,156,131
+6.2%
0.00%
-50.0%
Q4 2021$70,139,000
-14.5%
7,682,201
+0.1%
0.00%0.0%
Q3 2021$82,023,000
-29.7%
7,672,868
+2.0%
0.00%
-33.3%
Q2 2021$116,740,000
+0.9%
7,521,849
+5.4%
0.00%0.0%
Q1 2021$115,697,000
-20.6%
7,137,310
+3.6%
0.00%
-40.0%
Q4 2020$145,763,000
+68.8%
6,886,932
+18.2%
0.01%
+66.7%
Q3 2020$86,346,000
-7.1%
5,826,318
-7.8%
0.00%
-25.0%
Q2 2020$92,931,000
+40.1%
6,317,554
+11.8%
0.00%
+33.3%
Q1 2020$66,334,000
-51.1%
5,650,176
-2.0%
0.00%
-40.0%
Q4 2019$135,552,000
+44.4%
5,768,202
+13.7%
0.01%
+25.0%
Q3 2019$93,883,000
+3.0%
5,074,686
+3.5%
0.00%0.0%
Q2 2019$91,116,000
-23.3%
4,901,392
+0.9%
0.00%
-20.0%
Q1 2019$118,747,000
-6.8%
4,858,735
-1.1%
0.01%
-16.7%
Q4 2018$127,443,000
-15.8%
4,913,006
+2.8%
0.01%
-14.3%
Q3 2018$151,313,000
-14.3%
4,780,799
+5.2%
0.01%
-12.5%
Q2 2018$176,563,000
+82.1%
4,544,731
+29.4%
0.01%
+60.0%
Q1 2018$96,952,000
+79.9%
3,512,721
+18.0%
0.01%
+66.7%
Q4 2017$53,891,000
+15.6%
2,977,436
+3.2%
0.00%
+50.0%
Q3 2017$46,615,000
+20.4%
2,886,424
+3.2%
0.00%0.0%
Q2 2017$38,732,000
-2.7%
2,796,551
+5.3%
0.00%0.0%
Q1 2017$39,823,000
+107529.7%
2,654,845
+93479.3%
0.00%
Q4 2016$37,000
-40.3%
2,837
-21.8%
0.00%
Q3 2016$62,000
-16.2%
3,626
-11.6%
0.00%
Q2 2016$74,000
+80.5%
4,104
+94.2%
0.00%
Q1 2016$41,000
+105.0%
2,113
+176.2%
0.00%
Q4 2015$20,000
-23.1%
765
-27.4%
0.00%
Q3 2015$26,000
+52.9%
1,054
+90.3%
0.00%
Q2 2015$17,000
+112.5%
5540.0%0.00%
Q1 2015$8,000
+33.3%
5540.0%0.00%
Q4 2014$6,000
+20.0%
5540.0%0.00%
Q3 2014$5,000
-28.6%
5540.0%0.00%
Q2 2014$7,0005540.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders